Bezafibrate improves insulin resistance evaluated using the glucose clamp technique in patients with type 2 diabetes mellitus: a small-scale clinical study

BACKGROUND: Bezafibrate is mainly used to treat hypertriglyceridemia. Studies have reported that bezafibrate also improves type 2 diabetes mellitus, but the mechanism has not been fully elucidated. We performed euglycemic hyperinsulinemic clamps (glucose clamp) and meal tolerance tests (MTT) to exam...

Descripción completa

Detalles Bibliográficos
Autores principales: Shiochi, Hideki, Ohkura, Tsuyoshi, Fujioka, Yohei, Sumi, Keisuke, Yamamoto, Naoya, Nakanishi, Risa, Matsuzawa, Kazuhiko, Izawa, Schoichiro, Ohkura, Hiroko, Inoue, Kazuoki, Ueta, Etsuko, Kato, Masahiko, Taniguchi, Shin-ichi, Yamamoto, Kazuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4213459/
https://www.ncbi.nlm.nih.gov/pubmed/25360162
http://dx.doi.org/10.1186/1758-5996-6-113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4213459/
https://www.ncbi.nlm.nih.gov/pubmed/25360162
http://dx.doi.org/10.1186/1758-5996-6-113

Ejemplares similares